Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: JAMA Cardiol. 2016 Jul 1;1(4):389–396. doi: 10.1001/jamacardio.2016.0280

Table 3.

Risk of incident cancer among women with new-onset atrial fibrillation

Hazard ratio (95% confidence interval) P value
All atrial fibrillation events (N=1467)
  Crude 1.90 (1.61, 2.24) <0.001
  Age-adjusted 1.58 (1.34, 1.87) <0.001
  Multivariable adjusted* 1.48 (1.25, 1.75) <0.001
Paroxysmal atrial fibrillation (N=947)
  Crude 1.68 (1.36, 2.07) <0.001
  Age-adjusted 1.42 (1.15, 1.75) 0.001
  Multivariable adjusted* 1.37 (1.10, 1.69) 0.004
Non-paroxysmal atrial fibrillation (N=520)
  Crude 2.22 (1.71, 2.88) <0.001
  Age-adjusted 1.75 (1.35, 2.27) <0.001
  Multivariable adjusted* 1.50 (1.15, 1.96) 0.003
*

Adjusted for age, randomized treatment assignment, education, race/ethnicity and height at study entry, as well as time-dependent measures for body mass index, hypertension, hypercholesterolemia, diabetes, smoking status, number of cigarettes smoked per day, alcohol consumption, physical activity, hormone replacement therapy use, presence of a recent cancer screening test and incident non-fatal cardiovascular events (congestive heart failure, myocardial infarction or stroke). Due to missing data, multivariable models were based on 33789 participants.